Detalhe da pesquisa
1.
Neutrophil-to-lymphocyte ratio (NLR) predicts mortality in hospitalized geriatric patients independent of the admission diagnosis: a multicenter prospective cohort study.
J Transl Med
; 21(1): 835, 2023 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37990223
2.
Clusters of Comorbidities in the Short-Term Prognosis of Acute Heart Failure among Elderly Patients: A Retrospective Cohort Study.
Medicina (Kaunas)
; 58(10)2022 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36295555
3.
SOFA and qSOFA usefulness for in-hospital death prediction of elderly patients admitted for suspected infection in internal medicine.
Infection
; 48(6): 879-887, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32767020
4.
Serum levels of soluble suppression of tumorigenicity 2 (sST2) and heart-type fatty acid binding protein (H-FABP) independently predict in-hospital mortality in geriatric patients with COVID-19.
Mech Ageing Dev
; 216: 111876, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37802485
5.
Implementation of EHMRG Risk Model in an Italian Population of Elderly Patients with Acute Heart Failure.
J Clin Med
; 11(11)2022 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35683368
6.
Improving the EHMRG Prognostic Evaluation of Acute Heart Failure with TAPSE/PASp: A Sequential Approach.
Diagnostics (Basel)
; 12(2)2022 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35204569
7.
ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma.
Eur J Haematol
; 84(6): 474-83, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20331733
8.
Thalidomide-dexamethasone versus interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study.
Br J Haematol
; 144(5): 653-9, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19036082
9.
Serum C-reactive protein at diagnosis and response to therapy is the most powerful factor predicting outcome of multiple myeloma treated with thalidomide/ anthracycline-based therapy.
Clin Lymphoma Myeloma
; 8(5): 294-9, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18854284
10.
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.
Haematologica
; 91(1): 133-6, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16434383
11.
[Electrical cardioversion for atrial fibrillation: advantages of the transthoracic biphasic method]. / Cardioversione elettrica della fibrillazione atriale: vantaggio della cardioversione transtoracica ad onda bifasica.
Ital Heart J Suppl
; 3(6): 638-45, 2002 Jun.
Artigo
em Italiano
| MEDLINE | ID: mdl-12116814
12.
Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry.
Clin Lymphoma Myeloma Leuk
; 12(6): 423-32, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22981966
13.
Immunoglobulin G4-related disease in genitourinary organs: an emerging fibroinflammatory entity often misdiagnosed preoperatively as cancer.
Eur Urol
; 64(6): 865-72, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23266239
14.
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma.
Blood
; 108(7): 2159-64, 2006 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16763209